Hematide

Press Releases

Back
Affymax to Present at the 12th Annual BIO CEO & Investor Conference

PALO ALTO, Calif., Feb 01, 2010 (BUSINESS WIRE) -- Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, the company's president and chief executive officer, will present at the 12TH Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010 at 4:00 p.m. ET (1:00 p.m. PT).

A live webcast of the presentation will be available on the investors section of the Company's website at www.affymax.com. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional information, please visit www.affymax.com.

SOURCE: Affymax, Inc.

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications

Copyright Business Wire 2010

Back to top